Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/2977
The term “novel ingredients” in infant formula refers to bioactive compounds that go beyond traditional macronutrients and micronutrients—such as proteins, fats, carbohydrates, vitamins, and minerals—to more closely replicate the composition and functional benefits of human breast milk. A leading example is Milk Fat Globule Membrane (MFGM), a complex, tri-layered membrane that surrounds fat globules in breast milk. MFGM contains essential bioactive components, including phospholipids, cholesterol, and key proteins such as lactoferrin and osteopontin, which have been associated with improved cognitive development, neurological function, and immune system support in infants. Technological advancements in extraction and stabilization have recently enabled the integration of MFGM into commercially available infant formulas.
Simultaneously, the incorporation of novel prebiotics—non-digestible dietary fibers that selectively promote the growth of beneficial intestinal microbiota—is becoming increasingly prevalent. Among the most common are galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), both of which are widely recognized for their role in supporting gut health and overall infant wellness.
Consumer demand is steadily rising for infant formulas enriched with functional ingredients that address key aspects of early development, particularly in areas such as immunity, digestion, and cognitive performance. This demand is especially pronounced within the specialty formula segment, which caters to infants with specific nutritional or health-related needs. The growing use of prebiotics, probiotics, and postbiotics reflects a broader emphasis on fostering a healthy gut microbiome, which is increasingly understood to be a cornerstone of immune system development.
Concurrently, biotechnological innovations have enabled the production of advanced ingredients such as human milk oligosaccharides (HMOs) and MFGM, which closely mimic vital components of breast milk. These scientific developments are substantially improving the nutritional composition and functional efficacy of next-generation infant formulas, enhancing their suitability as alternatives when breastfeeding is not feasible.
List of Prominent Players in the Novel Ingredients in Infant Formula Market:
· DSM
· FrieslandCampina
· Novonesis (Chr. Hansen + Novozymes)
· DuPont (IFF Nutrition)
· BASF
· AAK
· Glycosyn
· Inbiose
· Kyowa Hakko
· Nestlé
· Danone (Nutricia)
· Abbott Nutrition
· Reckitt (Mead Johnson)
· Arla Foods
· Fonterra
· Helaina
· Biomilq
· 108LABS
· Turtletree Labs
· Else Nutrition
· ByHeart
· Sprout Organic
· Conagen
· Nature’s One
· Bactolife
· Evonik
· Glycotope
Market Dynamics
Drivers:
The growing emphasis on infant health and nutrition is a key driver behind the rising adoption of novel ingredients in the infant formula market. Today’s consumers are increasingly informed and health-conscious, resulting in heightened demand for premium-quality formulas fortified with advanced components such as human milk oligosaccharides (HMOs), milk fat globule membrane (MFGM), and bioengineered proteins. These ingredients are widely acknowledged for their contributions to immune support, digestive health, and cognitive development.
Furthermore, the increasing prevalence of food allergies, gastrointestinal conditions, and metabolic disorders among infants has intensified the need for specialized, hypoallergenic formulations. In response, manufacturers are directing significant investments toward research and development to design innovative products that meet evolving nutritional needs and align with consumer expectations for high-performance infant nutrition solutions.
Challenges:
Despite strong market potential, several challenges hinder the widespread adoption of novel ingredients. A primary constraint is the lengthy and complex regulatory approval process required for integrating new ingredients into infant formula products. These components must meet rigorous safety and efficacy criteria, often resulting in delays and additional costs. Additionally, the development and commercialization of such ingredients demand substantial research and development investments, along with access to advanced manufacturing capabilities. These requirements can present financial and operational obstacles, particularly for small to mid-sized companies seeking to enter or expand within the market.
Regional Trends:
The Asia-Pacific region remains the largest and fastest-growing market for infant formula, driven by relatively high birth rates, urbanization, and increasing disposable incomes. China, in particular, represents a major contributor to regional growth, supported by a robust retail infrastructure and policy shifts such as the relaxation of the one-child policy. However, the nation’s recent demographic shift—marked by declining birth rates and an aging population—is encouraging domestic dairy companies to diversify into adjacent segments, including adult nutrition.
In contrast, North America holds a leading position in the market for novel infant formula ingredients, supported by supportive regulatory frameworks and a strong emphasis on pediatric health. Consumer demand in this region is increasingly oriented toward organic, non-GMO, and clean-label formulations, reflecting heightened awareness around product quality, safety, and transparent sourcing. These regional dynamics are shaping the global trajectory of novel ingredient adoption in the infant nutrition sector.
Recent Developments:
· In April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich’s HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2′-O-Fucosyllactose (2′-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
· In Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
· In Sep 2023, Danone, the head of Danone’s early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers’ milk, according to Growth Asia.
Segmentation of Novel Ingredients in Infant Formula Market.
Global Novel Ingredients in Infant Formula Market – By Ingredient Type
· Human Milk Oligosaccharides (HMOs)
· Milk Fat Globule Membrane (MFGM)
· Synthetic/Bioengineered Proteins
· Next-Gen Probiotics
· Plant-Based Bioactives
· Glycomacropeptides (GMPs)
· Exosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market – By Application
· Standard Infant Formula
· Follow-On Formula
· Specialty Formula
· Growing-Up Milk
Global Novel Ingredients in Infant Formula Market – By Source
· Bioengineered
· Plant-Based
· Animal-Derived
Global Novel Ingredients in Infant Formula Market – By Region
North America-
· The US
· Canada
Europe-
· Germany
· The UK
· France
· Italy
· Spain
· Rest of Europe
Asia-Pacific-
· China
· Japan
· India
· South Korea
· Southeast Asia
· Rest of Asia Pacific
Latin America-
· Brazil
· Argentina
· Mexico
· Rest of Latin America
Middle East & Africa-
· GCC Countries
· South Africa
· Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
